The market of analgesics will continue to expand in constant value terms (2023 prices), although the rate of growth is expected to slow as the forecast period progress. Demand for pain relief will persist in the country, given the high number of respiratory illnesses circulating among the population, particularly during the winter months.
With consumers increasing demanding more ‘natural’ forms of pain relief, manufacturers are expected to enter the market with new herbal/traditional products which could challenge the position of well-established standard analgesics. GSK Consumer Healthcare, for example, has launched a new variant of Panadol in Australia called PanaNatra.
Despite the expected positive growth for analgesics, no changes are expected within the competitive landscape. Rather, it is expected that Panadol and Nurofen will continue to consolidate their respective positions and gradually capture a larger share of the market.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in New Zealand with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in New Zealand, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!